PENTAMIDINE ISETHIONATE

PENTAMIDINE ISETHIONATE was reported 1257 times

PENTAMIDINE ISETHIONATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BUCCAL POLYP 2 0.2500
1 BRONCHIAL ATRESIA 1 0.1429
2 HIV WASTING SYNDROME 3 0.0833
3 PNEUMOVIRUS TEST POSITIVE 2 0.0714
4 AIDS ENCEPHALOPATHY 4 0.0690
5 MYCOBACTERIUM AVIUM COMPLEX IMMUNE RESTORATION DISEASE 2 0.0690
6 PREMATURE CLOSURE OF CRANIAL SUTURES 2 0.0526
7 ACANTHAMOEBA INFECTION 9 0.0479
8 RHODOCOCCUS INFECTION 7 0.0422
9 TOOTH DISLOCATION 2 0.0351
10 CASTLEMAN'S DISEASE 2 0.0345
11 HAEMATOPOIETIC STEM CELL MOBILISATION 2 0.0312
12 MALACOPLAKIA GASTROINTESTINAL 3 0.0306
13 MALASSEZIA INFECTION 2 0.0294
14 BRONCHOALVEOLAR LAVAGE ABNORMAL 6 0.0288
15 ANTINUCLEAR ANTIBODY NEGATIVE 1 0.0286
16 PNEUMOCYSTIS TEST POSITIVE 2 0.0278
17 BLOOD STEM CELL HARVEST 1 0.0270
18 RESTRICTIVE CARDIOMYOPATHY 8 0.0264
19 CONDYLOMA ACUMINATUM 1 0.0256
20 ALEXIA 2 0.0247
21 ARTERIOVENOUS FISTULA ANEURYSM 1 0.0244
22 CENTRAL NERVOUS SYSTEM IMMUNE RECONSTITUTION INFLAMMATORY RESPONSE 1 0.0238
23 GRAFT VERSUS HOST DISEASE IN INTESTINE 3 0.0231
24 CYTOMEGALOVIRUS TEST 1 0.0222
25 THORACOTOMY 3 0.0210
26 MEDULLOBLASTOMA 3 0.0201
27 SYNOSTOSIS 2 0.0190
28 PARENTERAL NUTRITION 4 0.0173
29 DIABETES WITH HYPEROSMOLARITY 1 0.0172
30 DISSEMINATED TOXOPLASMOSIS 2 0.0167
31 KAPOSI'S SARCOMA 8 0.0159
32 CARDIOTHORACIC RATIO INCREASED 1 0.0159
33 ABDOMINAL WALL OEDEMA 1 0.0159
34 QUADRANTANOPIA 2 0.0153
35 APLASTIC ANAEMIA 77 0.0147
36 HEPATOJUGULAR REFLUX 2 0.0120
37 INFECTIVE MYOSITIS 2 0.0120
38 MALACOPLAKIA 5 0.0109
39 PNEUMOCYSTIS JIROVECI PNEUMONIA 24 0.0108
40 BACTERIA STOOL IDENTIFIED 2 0.0105
41 BRONCHIOLOALVEOLAR CARCINOMA 1 0.0103
42 TOXOPLASMOSIS 11 0.0102
43 AMOEBIC DYSENTERY 1 0.0101
44 BRACHYCEPHALY 1 0.0099
45 PNEUMOCYSTIS CARINII PNEUMONIA 2 0.0099
46 CAROTID ARTERY ATHEROMA 1 0.0094
47 IMMUNE RECONSTITUTION SYNDROME 12 0.0093
48 CYTOMEGALOVIRUS GASTROENTERITIS 2 0.0093
49 FACIAL DYSMORPHISM 2 0.0090
50 CATHETER THROMBOSIS 1 0.0089
51 STAPHYLOCOCCAL SCALDED SKIN SYNDROME 2 0.0089
52 BLOOD LACTATE DEHYDROGENASE ABNORMAL 6 0.0088
53 CEREBRAL TOXOPLASMOSIS 8 0.0086
54 CENTRAL VENOUS PRESSURE INCREASED 1 0.0082
55 RENAL ARTERIOSCLEROSIS 2 0.0082
56 ADENOIDITIS 1 0.0079
57 HEART TRANSPLANT 7 0.0077
58 CYTOKINE INCREASED 1 0.0074
59 PNEUMOCYSTIS JIROVECI INFECTION 2 0.0072
60 AGONAL RESPIRATION 2 0.0071
61 VENOOCCLUSIVE DISEASE 17 0.0068
62 ENGRAFTMENT SYNDROME 4 0.0068
63 BLOOD BETA-D-GLUCAN INCREASED 2 0.0065
64 ASPIRATION PLEURAL CAVITY 5 0.0065
65 ASPERGILLUS TEST POSITIVE 2 0.0065
66 CREATININE URINE DECREASED 1 0.0063
67 CONTRACTED BLADDER 1 0.0062
68 RESPIRATORY MUSCLE WEAKNESS 2 0.0062
69 BLOOD OSMOLARITY INCREASED 2 0.0061
70 ANAPLASTIC ASTROCYTOMA 1 0.0061
71 ANAL SKIN TAGS 1 0.0061
72 RETINAL TOXICITY 6 0.0058
73 HYPERALDOSTERONISM 2 0.0058
74 PULMONARY CAVITATION 5 0.0057
75 DELAYED GRAFT FUNCTION 4 0.0056
76 BLOOD ZINC DECREASED 1 0.0055
77 PLATELET TRANSFUSION 7 0.0054
78 ACINETOBACTER BACTERAEMIA 1 0.0053
79 APLASIA 10 0.0051
80 EYE INFECTION TOXOPLASMAL 2 0.0050
81 ECTHYMA 2 0.0050
82 DEAFNESS CONGENITAL 1 0.0050
83 TRICHOSPORON INFECTION 2 0.0049
84 HYPERTELORISM OF ORBIT 2 0.0048
85 CANDIDA TEST POSITIVE 2 0.0048
86 AUTOINFLAMMATORY DISEASE 1 0.0047
87 URINARY TRACT INFECTION STAPHYLOCOCCAL 2 0.0047
88 THREATENED LABOUR 2 0.0047
89 BLOOD STEM CELL TRANSPLANT FAILURE 1 0.0047
90 HYPERFERRITINAEMIA 2 0.0046
91 DISSEMINATED CYTOMEGALOVIRAL INFECTION 1 0.0046
92 GASTROINTESTINAL MUCOSAL DISORDER 3 0.0046
93 BONE MARROW TRANSPLANT REJECTION 1 0.0045
94 REFUSAL OF TREATMENT BY RELATIVE 2 0.0044
95 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 2 0.0044
96 EAR MALFORMATION 2 0.0043
97 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 1 0.0043
98 URINARY TRACT INFECTION ENTEROCOCCAL 4 0.0043
99 COLD TYPE HAEMOLYTIC ANAEMIA 1 0.0043
100 ACUTE LUNG INJURY 5 0.0042
101 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 3 0.0042
102 CHRONIC GRAFT VERSUS HOST DISEASE 15 0.0042
103 BLOOD URIC ACID DECREASED 2 0.0041
104 CYTOMEGALOVIRUS CHORIORETINITIS 8 0.0041
105 HAEMATOTOXICITY 38 0.0040
106 BONE MARROW RETICULIN FIBROSIS 1 0.0039
107 ALVEOLITIS ALLERGIC 4 0.0039
108 MUCORMYCOSIS 10 0.0038
109 MYCOPLASMA INFECTION 3 0.0038
110 PLASMAPHERESIS 2 0.0038
111 METAPNEUMOVIRUS INFECTION 3 0.0038
112 ADENOVIRUS INFECTION 11 0.0038
113 POLYPECTOMY 3 0.0037
114 ENTEROCOCCAL SEPSIS 3 0.0037
115 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 10 0.0036
116 CEREBRAL FUNGAL INFECTION 1 0.0035
117 BURKHOLDERIA CEPACIA COMPLEX INFECTION 1 0.0035
118 CATHETER SITE CELLULITIS 1 0.0034
119 MYCOBACTERIUM AVIUM COMPLEX INFECTION 9 0.0033
120 CREATININE URINE INCREASED 1 0.0033
121 MEDICAL DEVICE SITE INFECTION 2 0.0032
122 RENAL ATROPHY 4 0.0032
123 ANOMALY OF EXTERNAL EAR CONGENITAL 1 0.0032
124 BACILLUS INFECTION 2 0.0032
125 BOWEL SOUNDS ABNORMAL 1 0.0032
126 DRUG CLEARANCE DECREASED 4 0.0031
127 COAGULATION FACTOR V LEVEL DECREASED 1 0.0031
128 CATHETER SITE IRRITATION 1 0.0030
129 ECTROPION 1 0.0030
130 GRAFT VERSUS HOST DISEASE 21 0.0029
131 BILIARY CIRRHOSIS PRIMARY 1 0.0029
132 ANION GAP DECREASED 1 0.0029
133 PSEUDOMONAL SEPSIS 5 0.0029
134 JOINT CONTRACTURE 3 0.0028
135 VOCAL CORD PARALYSIS 5 0.0028
136 VASOGENIC CEREBRAL OEDEMA 2 0.0028
137 VISCERAL LEISHMANIASIS 2 0.0028
138 SYPHILIS 2 0.0028
139 CENTRAL LINE INFECTION 1 0.0027
140 HYPERCAPNIA 8 0.0027
141 BONE MARROW TRANSPLANT 5 0.0026
142 HYPOPROTEINAEMIA 5 0.0026
143 PARAINFLUENZAE VIRUS INFECTION 4 0.0026
144 AMYOTROPHY 1 0.0026
145 CHONDROCALCINOSIS PYROPHOSPHATE 2 0.0026
146 FUNGAEMIA 4 0.0025
147 OPHTHALMOPLEGIA 4 0.0025
148 BRAIN COMPRESSION 1 0.0025
149 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 2 0.0025
150 STAPHYLOCOCCAL SKIN INFECTION 3 0.0024
151 CARDIAC VENTRICULAR DISORDER 1 0.0024
152 BLOOD ELECTROLYTES ABNORMAL 3 0.0024
153 STEM CELL TRANSPLANT 6 0.0024
154 LUNG ABSCESS 5 0.0024
155 ABDOMINAL CAVITY DRAINAGE 1 0.0024
156 APPARENT LIFE THREATENING EVENT 1 0.0024
157 CORONA VIRUS INFECTION 1 0.0023
158 ACUTE SINUSITIS 4 0.0023
159 CRANIOSYNOSTOSIS 2 0.0023
160 AUTOIMMUNE THROMBOCYTOPENIA 1 0.0023
161 OBLITERATIVE BRONCHIOLITIS 3 0.0023
162 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
163 CYSTITIS HAEMORRHAGIC 9 0.0022
164 URETERIC OBSTRUCTION 3 0.0022
165 MUCOSAL INFLAMMATION 57 0.0022
166 EXTENSOR PLANTAR RESPONSE 2 0.0022
167 DYSPHASIA 1 0.0021
168 PERIPHERAL MOTOR NEUROPATHY 3 0.0021
169 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 5 0.0021
170 MYELITIS TRANSVERSE 3 0.0021
171 BRAIN STEM HAEMORRHAGE 2 0.0021
172 MULTIPLE CONGENITAL ABNORMALITIES 3 0.0021
173 ANAL CANCER 2 0.0021
174 CARDIAC VALVE VEGETATION 1 0.0021
175 PNEUMONIA CYTOMEGALOVIRAL 4 0.0021
176 CONTINUOUS HAEMODIAFILTRATION 2 0.0020
177 FEBRILE NEUTROPENIA 135 0.0020
178 PNEUMONIA PNEUMOCOCCAL 3 0.0020
179 PYURIA 2 0.0020
180 IMPETIGO 3 0.0020
181 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 1 0.0020
182 PNEUMOCYSTIS JIROVECII PNEUMONIA 20 0.0020
183 CALCULUS URINARY 3 0.0019
184 CEREBRAL ARTERY THROMBOSIS 1 0.0019
185 ACQUIRED IMMUNODEFICIENCY SYNDROME 1 0.0019
186 WALKING DISABILITY 4 0.0019
187 CRYPTOSPORIDIOSIS INFECTION 1 0.0019
188 SYSTOLIC DYSFUNCTION 2 0.0019
189 CONVULSION NEONATAL 1 0.0019
190 CORYNEBACTERIUM INFECTION 1 0.0019
191 B-CELL LYMPHOMA RECURRENT 1 0.0018
192 STREPTOCOCCAL BACTERAEMIA 2 0.0018
193 ACINETOBACTER INFECTION 2 0.0018
194 PNEUMONIA STREPTOCOCCAL 2 0.0018
195 CLOSTRIDIUM TEST POSITIVE 4 0.0018
196 BLOOD MAGNESIUM ABNORMAL 1 0.0018
197 CYTOMEGALOVIRUS VIRAEMIA 8 0.0018
198 VANISHING BILE DUCT SYNDROME 2 0.0018
199 CARDIAC HYPERTROPHY 2 0.0018
200 MULTI-ORGAN FAILURE 31 0.0018
201 BK VIRUS INFECTION 6 0.0018
202 CLOSTRIDIAL INFECTION 6 0.0018
203 OESOPHAGEAL CANDIDIASIS 7 0.0018
204 BLOOD AMYLASE INCREASED 3 0.0018
205 ACUTE GRAFT VERSUS HOST DISEASE 8 0.0017
206 DIFFUSE ALVEOLAR DAMAGE 2 0.0017
207 CARBON DIOXIDE DECREASED 2 0.0017
208 TRANSFUSION 18 0.0017
209 LIVER TRANSPLANT REJECTION 3 0.0017
210 BLEEDING TIME PROLONGED 2 0.0017
211 CONDUCTION DISORDER 3 0.0016
212 DIAPHRAGMATIC HERNIA 1 0.0016
213 STAPHYLOCOCCAL BACTERAEMIA 7 0.0016
214 ARTHRITIS REACTIVE 1 0.0016
215 GASTROINTESTINAL TUBE INSERTION 4 0.0016
216 NEPHRITIS INTERSTITIAL 2 0.0016
217 LIPIDS INCREASED 3 0.0015
218 STENOTROPHOMONAS INFECTION 2 0.0015
219 NEUTROPENIC COLITIS 3 0.0014
220 PERITONEAL HAEMORRHAGE 2 0.0014
221 PULMONARY ALVEOLAR HAEMORRHAGE 8 0.0014
222 RENAL TUBULAR DISORDER 4 0.0014
223 OPTIC NEUROPATHY 3 0.0014
224 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0014
225 FEBRILE BONE MARROW APLASIA 6 0.0014
226 ALPHA 1 FOETOPROTEIN INCREASED 1 0.0014
227 LUNG NEOPLASM 6 0.0014
228 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 7 0.0014
229 CD4 LYMPHOCYTES DECREASED 3 0.0014
230 CALCULUS URETERIC 1 0.0014
231 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
232 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 2 0.0014
233 CLONIC CONVULSION 1 0.0014
234 FAILURE TO THRIVE 7 0.0013
235 CREATININE RENAL CLEARANCE INCREASED 1 0.0013
236 NEPHROGENIC SYSTEMIC FIBROSIS 4 0.0013
237 GINGIVAL HYPERTROPHY 2 0.0013
238 LICHENOID KERATOSIS 3 0.0013
239 PORTAL HYPERTENSION 4 0.0013
240 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 3 0.0013
241 BILIRUBIN CONJUGATED INCREASED 3 0.0013
242 CHRONIC ALLOGRAFT NEPHROPATHY 1 0.0013
243 INFUSION SITE SWELLING 8 0.0013
244 BACTERAEMIA 15 0.0013
245 INTRA-ABDOMINAL HAEMORRHAGE 3 0.0013
246 VARICELLA 3 0.0013
247 HYPERURICAEMIA 5 0.0012
248 VENOOCCLUSIVE LIVER DISEASE 6 0.0012
249 BOTULISM 1 0.0012
250 CSF PROTEIN INCREASED 1 0.0012
251 COLLAPSE OF LUNG 1 0.0012
252 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 9 0.0012
253 LEUKAEMIA RECURRENT 2 0.0012
254 EROSIVE OESOPHAGITIS 2 0.0012
255 NOCARDIOSIS 3 0.0012
256 ELECTRIC SHOCK 1 0.0012
257 APLASIA PURE RED CELL 4 0.0012
258 RETINITIS 2 0.0012
259 KIDNEY FIBROSIS 2 0.0012
260 PULMONARY HAEMORRHAGE 9 0.0011
261 TORSADE DE POINTES 9 0.0011
262 CEREBELLAR ATROPHY 1 0.0011
263 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 2 0.0011
264 KYPHOSIS 2 0.0011
265 CERUMEN IMPACTION 1 0.0011
266 PNEUMONIA BACTERIAL 10 0.0011
267 COLOUR BLINDNESS 1 0.0011
268 BONE MARROW FAILURE 22 0.0011
269 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
270 OPPORTUNISTIC INFECTION 2 0.0011
271 BONE CYST 1 0.0011
272 BLOOD IRON INCREASED 2 0.0011
273 HUMAN HERPESVIRUS 6 INFECTION 2 0.0011
274 BLADDER CATHETERISATION 1 0.0010
275 BRONCHOPULMONARY ASPERGILLOSIS 8 0.0010
276 RHINOVIRUS INFECTION 4 0.0010
277 CYTOMEGALOVIRUS INFECTION 17 0.0010
278 DACTYLITIS 1 0.0010
279 LUNG INFILTRATION 9 0.0010
280 PNEUMONIA FUNGAL 4 0.0010
281 BLOOD ALBUMIN DECREASED 8 0.0010
282 ANORECTAL DISORDER 2 0.0010
283 BLOOD CULTURE POSITIVE 3 0.0010
284 VARICES OESOPHAGEAL 3 0.0010
285 AUTONOMIC NEUROPATHY 1 0.0010
286 FIBROSIS 3 0.0010
287 PANCYTOPENIA 54 0.0010
288 ILEUS 12 0.0010
289 SKIN INDURATION 2 0.0010
290 AXILLARY MASS 1 0.0010
291 INFUSION SITE ERYTHEMA 8 0.0009
292 EYE CONTUSION 2 0.0009
293 BONE DEMINERALISATION 1 0.0009
294 TORTICOLLIS 2 0.0009
295 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 2 0.0009
296 BONE NEOPLASM 1 0.0009
297 LIVER ABSCESS 3 0.0009
298 THROMBOTIC MICROANGIOPATHY 9 0.0009
299 HERPES SIMPLEX 6 0.0009
300 BACTERIAL SEPSIS 3 0.0009
301 HYPERLIPIDAEMIA 11 0.0009
302 ASPERGILLUS INFECTION 6 0.0009
303 BRONCHOSPASM 13 0.0009
304 GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0009
305 TONGUE ULCERATION 3 0.0009
306 CHOLECYSTITIS ACUTE 5 0.0009
307 COMPLICATIONS OF TRANSPLANTED KIDNEY 2 0.0009
308 BRONCHOPNEUMONIA 3 0.0009
309 CORTISOL DECREASED 1 0.0009
310 CYTOMEGALOVIRUS COLITIS 2 0.0009
311 NEUROLOGICAL DECOMPENSATION 2 0.0009
312 MULTIPLE MYELOMA 4 0.0009
313 BONE MARROW TOXICITY 1 0.0008
314 PLEURISY 5 0.0008
315 BONE LESION 3 0.0008
316 DIABETES INSIPIDUS 2 0.0008
317 PULSE ABNORMAL 2 0.0008
318 STAPHYLOCOCCAL SEPSIS 4 0.0008
319 BLOOD UREA DECREASED 1 0.0008
320 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
321 SYSTEMIC CANDIDA 2 0.0008
322 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 4 0.0008
323 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 4 0.0008
324 LIPASE INCREASED 6 0.0008
325 HEPATOSPLENOMEGALY 2 0.0008
326 BLOOD CHLORIDE DECREASED 2 0.0008
327 ABDOMINAL OPERATION 1 0.0008
328 ASPERGILLOSIS 1 0.0008
329 BLOOD LACTIC ACID INCREASED 4 0.0008
330 LUNG OPACITY 2 0.0008
331 BLOOD LACTATE DEHYDROGENASE INCREASED 12 0.0008
332 NYSTAGMUS 4 0.0008
333 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
334 CANDIDIASIS 3 0.0007
335 CORNEAL OPACITY 1 0.0007
336 CLONUS 2 0.0007
337 ABSCESS ORAL 1 0.0007
338 ENCEPHALITIS 5 0.0007
339 HEPATOMEGALY 7 0.0007
340 CULTURE URINE POSITIVE 1 0.0007
341 SKIN HYPERTROPHY 2 0.0007
342 DISSEMINATED INTRAVASCULAR COAGULATION 10 0.0007
343 ALVEOLITIS 1 0.0007
344 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
345 OXYGEN SATURATION ABNORMAL 2 0.0007
346 PERONEAL NERVE PALSY 4 0.0007
347 PULMONARY TUBERCULOSIS 3 0.0007
348 PARAPLEGIA 2 0.0007
349 BLOOD URIC ACID INCREASED 4 0.0007
350 RALES 4 0.0007
351 PERIPHERAL SENSORY NEUROPATHY 4 0.0007
352 TUMOUR LYSIS SYNDROME 6 0.0007
353 ACUTE ABDOMEN 1 0.0007
354 BLOOD TRIGLYCERIDES INCREASED 12 0.0007
355 ACUTE RESPIRATORY DISTRESS SYNDROME 12 0.0007
356 BLOOD CREATINE INCREASED 3 0.0007
357 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
358 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 4 0.0007
359 HEPATITIS FULMINANT 2 0.0007
360 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
361 HYDRONEPHROSIS 5 0.0007
362 VASCULAR DEVICE INFECTION 3 0.0007
363 ASTIGMATISM 1 0.0007
364 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
365 DIASTOLIC DYSFUNCTION 2 0.0006
366 FAMILY STRESS 2 0.0006
367 TALIPES 2 0.0006
368 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
369 GAMMA-GLUTAMYLTRANSFERASE INCREASED 14 0.0006
370 PNEUMOTHORAX 10 0.0006
371 BLOOD BILIRUBIN INCREASED 17 0.0006
372 HEPATOTOXICITY 14 0.0006
373 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
374 LYMPHOCYTE COUNT INCREASED 2 0.0006
375 POLYP 4 0.0006
376 DEAFNESS NEUROSENSORY 2 0.0006
377 WALKING AID USER 4 0.0006
378 PEPTIC ULCER 2 0.0006
379 ANTIBODY TEST POSITIVE 1 0.0006
380 HYPERNATRAEMIA 3 0.0006
381 ANXIETY DISORDER 2 0.0006
382 NEUTROPHIL COUNT DECREASED 24 0.0006
383 FACIAL PARALYSIS 5 0.0006
384 PANCREATITIS 31 0.0006
385 CACHEXIA 3 0.0006
386 HEPATIC FIBROSIS 2 0.0006
387 LEFT VENTRICULAR FAILURE 2 0.0006
388 MYOPATHY 5 0.0006
389 HERPES ZOSTER 33 0.0006
390 NEUTROPENIA 78 0.0006
391 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
392 RENAL FAILURE ACUTE 24 0.0006
393 BLOOD ALKALINE PHOSPHATASE INCREASED 14 0.0006
394 APPENDICECTOMY 2 0.0006
395 HAEMOLYTIC ANAEMIA 5 0.0006
396 CHEILITIS 3 0.0006
397 BLOOD HIV RNA INCREASED 1 0.0006
398 CEREBRAL VENOUS THROMBOSIS 1 0.0006
399 LIVER TRANSPLANT 2 0.0005
400 NECROSIS 3 0.0005
401 LEUKOENCEPHALOPATHY 2 0.0005
402 BLADDER SPASM 1 0.0005
403 HEPATIC NECROSIS 2 0.0005
404 GRANULOCYTOPENIA 3 0.0005
405 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
406 SEPSIS 58 0.0005
407 DIFFUSE LARGE B-CELL LYMPHOMA 4 0.0005
408 HYPOVOLAEMIA 3 0.0005
409 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
410 ASCITES 15 0.0005
411 VENOUS THROMBOSIS 2 0.0005
412 POLYDIPSIA 2 0.0005
413 CELL DEATH 1 0.0005
414 TRICUSPID VALVE INCOMPETENCE 4 0.0005
415 ODYNOPHAGIA 3 0.0005
416 HEPATITIS B 3 0.0005
417 RESPIRATORY FAILURE 36 0.0005
418 EYELID PTOSIS 5 0.0005
419 CAPILLARY LEAK SYNDROME 1 0.0005
420 HYPERBILIRUBINAEMIA 5 0.0005
421 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
422 BODY TEMPERATURE FLUCTUATION 1 0.0005
423 CONGESTIVE CARDIOMYOPATHY 2 0.0005
424 DILATATION VENTRICULAR 1 0.0005
425 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
426 ANOREXIA 6 0.0005
427 THROMBOCYTOPENIA 52 0.0005
428 CEREBELLAR SYNDROME 1 0.0005
429 DIABETIC NEPHROPATHY 1 0.0005
430 COLONOSCOPY 1 0.0005
431 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 1 0.0005
432 IMMUNOSUPPRESSION 4 0.0005
433 RESPIRATORY RATE INCREASED 4 0.0005
434 CYTOKINE RELEASE SYNDROME 9 0.0004
435 BACTERIAL TEST POSITIVE 1 0.0004
436 CARDIOTOXICITY 4 0.0004
437 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
438 URINE ABNORMALITY 2 0.0004
439 ABSCESS 7 0.0004
440 SEPTIC SHOCK 19 0.0004
441 RESPIRATORY DISTRESS 12 0.0004
442 APHTHOUS STOMATITIS 1 0.0004
443 GRAND MAL CONVULSION 4 0.0004
444 PERICARDIAL EFFUSION 10 0.0004
445 PULMONARY HYPERTENSION 9 0.0004
446 PLATELET COUNT DECREASED 46 0.0004
447 HEPATIC FUNCTION ABNORMAL 16 0.0004
448 HEPATIC ENCEPHALOPATHY 4 0.0004
449 SPLENOMEGALY 5 0.0004
450 SKIN TIGHTNESS 2 0.0004
451 DYSMORPHISM 1 0.0004
452 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
453 MYELODYSPLASTIC SYNDROME 6 0.0004
454 ATELECTASIS 4 0.0004
455 ENTEROCOCCAL INFECTION 2 0.0004
456 GUILLAIN-BARRE SYNDROME 2 0.0004
457 FLUID OVERLOAD 6 0.0004
458 STOMATITIS 25 0.0004
459 HYPOKALAEMIA 19 0.0004
460 CYTOPENIA 5 0.0004
461 RENAL TUBULAR NECROSIS 4 0.0004
462 HYPOPHOSPHATAEMIA 3 0.0004
463 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
464 ABDOMINAL TENDERNESS 2 0.0004
465 DERMATITIS EXFOLIATIVE 2 0.0004
466 KLEBSIELLA INFECTION 2 0.0004
467 BRAIN ABSCESS 1 0.0004
468 CHEMICAL BURN OF SKIN 1 0.0004
469 ACIDOSIS 3 0.0004
470 HYPOPHAGIA 10 0.0004
471 DISSEMINATED TUBERCULOSIS 1 0.0004
472 CEREBRAL ISCHAEMIA 2 0.0004
473 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
474 PYREXIA 134 0.0004
475 HIATUS HERNIA 5 0.0004
476 RENAL CYST 3 0.0004
477 ASPARTATE AMINOTRANSFERASE INCREASED 20 0.0004
478 BLOOD POTASSIUM ABNORMAL 1 0.0004
479 BLOOD DISORDER 3 0.0004
480 TUBULOINTERSTITIAL NEPHRITIS 7 0.0004
481 ALCOHOL POISONING 1 0.0004
482 BLOOD SODIUM INCREASED 1 0.0004
483 ENCEPHALOPATHY 9 0.0004
484 BLOOD PHOSPHORUS INCREASED 1 0.0004
485 GINGIVAL BLEEDING 5 0.0004
486 ESCHERICHIA INFECTION 3 0.0004
487 ACUTE RESPIRATORY FAILURE 7 0.0004
488 PLEURAL EFFUSION 22 0.0004
489 MENTAL STATUS CHANGES 10 0.0004
490 EOSINOPHIL COUNT INCREASED 3 0.0004
491 STREPTOCOCCAL INFECTION 2 0.0004
492 HYPOMAGNESAEMIA 5 0.0004
493 LYMPHOPENIA 5 0.0004
494 SUBDURAL HAEMATOMA 5 0.0003
495 EXERCISE TOLERANCE DECREASED 2 0.0003
496 SKIN ATROPHY 2 0.0003
497 HYPERTRIGLYCERIDAEMIA 2 0.0003
498 HYPONATRAEMIA 19 0.0003
499 BRAIN HERNIATION 1 0.0003
500 PROTHROMBIN TIME PROLONGED 2 0.0003
501 RESPIRATORY DISORDER 10 0.0003
502 DEVELOPMENTAL DELAY 3 0.0003
503 CEREBROVASCULAR DISORDER 1 0.0003
504 HYPOAESTHESIA ORAL 5 0.0003
505 CENTRAL VENOUS CATHETERISATION 1 0.0003
506 BONE MARROW DISORDER 1 0.0003
507 ADRENAL INSUFFICIENCY 4 0.0003
508 NO THERAPEUTIC RESPONSE 4 0.0003
509 DIABETIC FOOT 1 0.0003
510 LUNG DISORDER 16 0.0003
511 CHEST X-RAY ABNORMAL 1 0.0003
512 CARDIOMEGALY 4 0.0003
513 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
514 GENERALISED OEDEMA 4 0.0003
515 OLIGURIA 2 0.0003
516 ERYTHEMA MULTIFORME 3 0.0003
517 BACTERIAL INFECTION 6 0.0003
518 APPENDICITIS 3 0.0003
519 ACUTE MYELOID LEUKAEMIA 5 0.0003
520 BLOOD BLISTER 1 0.0003
521 ARTERIOSCLEROSIS 3 0.0003
522 MUSCLE ATROPHY 4 0.0003
523 GASTRIC ULCER 6 0.0003
524 BILE DUCT STONE 1 0.0003
525 CUSHINGOID 1 0.0003
526 ALANINE AMINOTRANSFERASE INCREASED 19 0.0003
527 AUTOIMMUNE DISORDER 3 0.0003
528 HYPOGAMMAGLOBULINAEMIA 2 0.0003
529 ORAL CANDIDIASIS 4 0.0003
530 STAPHYLOCOCCAL INFECTION 10 0.0003
531 HAEMATOCRIT DECREASED 6 0.0003
532 HYPERGLYCAEMIA 11 0.0003
533 CYTOLYTIC HEPATITIS 1 0.0003
534 COAGULOPATHY 5 0.0003
535 LEUKOPENIA 15 0.0003
536 MENINGITIS 2 0.0003
537 BLOOD UREA INCREASED 5 0.0003
538 PERICARDITIS 5 0.0003
539 HYPOTHERMIA 3 0.0003
540 B-CELL LYMPHOMA 1 0.0003
541 DRUG TOXICITY 4 0.0003
542 LIVER DISORDER 13 0.0003
543 NEPHROTIC SYNDROME 2 0.0003
544 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
545 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
546 WEIGHT FLUCTUATION 3 0.0003
547 WHITE BLOOD CELL COUNT DECREASED 31 0.0003
548 HYPERKALAEMIA 10 0.0003
549 BRONCHIOLITIS 1 0.0003
550 HYPOXIA 10 0.0003
551 PAPULE 2 0.0003
552 LYMPHOCYTE COUNT DECREASED 5 0.0003
553 PULMONARY TOXICITY 2 0.0003
554 SINUS TACHYCARDIA 4 0.0003
555 RED BLOOD CELL COUNT DECREASED 8 0.0003
556 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
557 PARAESTHESIA ORAL 4 0.0003
558 GASTROENTERITIS VIRAL 5 0.0003
559 TONGUE DISORDER 2 0.0003
560 RASH PUSTULAR 2 0.0003
561 CAROTID ARTERY OCCLUSION 1 0.0003
562 GASTROENTERITIS 4 0.0003
563 BLOOD PHOSPHORUS DECREASED 1 0.0003
564 HEPATITIS 7 0.0003
565 MOUTH HAEMORRHAGE 2 0.0003
566 AMYLASE INCREASED 1 0.0003
567 CEREBRAL DISORDER 2 0.0003
568 HEPATIC STEATOSIS 5 0.0003
569 PANCREATITIS ACUTE 6 0.0003
570 BLOOD CALCIUM DECREASED 3 0.0003
571 MITRAL VALVE INCOMPETENCE 3 0.0003
572 BLOOD COUNT ABNORMAL 4 0.0003
573 CHOLESTASIS 5 0.0003
574 HAEMOLYSIS 2 0.0003
575 LYMPHOMA 4 0.0003
576 PNEUMONITIS 7 0.0003
577 NEUROPATHY PERIPHERAL 24 0.0003
578 GINGIVAL PAIN 2 0.0003
579 ATRIAL FLUTTER 2 0.0003
580 AZOTAEMIA 1 0.0003
581 APPLICATION SITE DISCOLOURATION 1 0.0002
582 POLYURIA 2 0.0002
583 DEMYELINATION 1 0.0002
584 SMALL INTESTINAL OBSTRUCTION 3 0.0002
585 ARTHRITIS BACTERIAL 1 0.0002
586 HYPERCALCAEMIA 3 0.0002
587 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
588 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
589 SPINAL COMPRESSION FRACTURE 2 0.0002
590 HEMIPLEGIA 2 0.0002
591 BRAIN OEDEMA 3 0.0002
592 CANDIDA INFECTION 4 0.0002
593 CIRCULATORY COLLAPSE 4 0.0002
594 PSEUDOMONAS INFECTION 2 0.0002
595 UNRESPONSIVE TO STIMULI 6 0.0002
596 ANURIA 2 0.0002
597 HEPATIC FAILURE 7 0.0002
598 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
599 CHAPPED LIPS 1 0.0002
600 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
601 URINE OUTPUT DECREASED 2 0.0002
602 NEUROTOXICITY 4 0.0002
603 ABDOMINAL ABSCESS 1 0.0002
604 PURPURA 2 0.0002
605 ANAEMIA 43 0.0002
606 RASH MACULO-PAPULAR 5 0.0002
607 HAEMOGLOBIN DECREASED 23 0.0002
608 PULMONARY OEDEMA 10 0.0002
609 ORAL PAIN 5 0.0002
610 ANAL INCONTINENCE 2 0.0002
611 LEUKOCYTOSIS 4 0.0002
612 TACHYPNOEA 3 0.0002
613 OPTIC NEURITIS 2 0.0002
614 PATHOGEN RESISTANCE 2 0.0002
615 METABOLIC ACIDOSIS 7 0.0002
616 EAR DISORDER 1 0.0002
617 RETINAL DETACHMENT 2 0.0002
618 TACHYCARDIA 19 0.0002
619 HEPATIC CIRRHOSIS 4 0.0002
620 COLITIS 8 0.0002
621 CONVULSION 12 0.0002
622 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
623 BREATH SOUNDS ABNORMAL 1 0.0002
624 BLOOD POTASSIUM DECREASED 6 0.0002
625 TOXIC SKIN ERUPTION 2 0.0002
626 EMPHYSEMA 2 0.0002
627 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
628 HAEMATEMESIS 5 0.0002
629 MOTOR DYSFUNCTION 2 0.0002
630 AMMONIA INCREASED 1 0.0002
631 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
632 HELICOBACTER INFECTION 2 0.0002
633 PNEUMONIA 62 0.0002
634 DEAFNESS 5 0.0002
635 CYANOSIS 3 0.0002
636 ANHEDONIA 5 0.0002
637 MOUTH ULCERATION 4 0.0002
638 ANAL FISSURE 1 0.0002
639 DYSPNOEA EXERTIONAL 7 0.0002
640 JAUNDICE 5 0.0002
641 HYPOGLYCAEMIA 9 0.0002
642 WHEEZING 11 0.0002
643 BEHAVIOUR DISORDER 1 0.0002
644 BLOOD CREATININE INCREASED 12 0.0002
645 OESOPHAGITIS 2 0.0002
646 OSTEONECROSIS 6 0.0002
647 WOUND INFECTION 2 0.0002
648 ASPIRATION 2 0.0002
649 DEAFNESS UNILATERAL 1 0.0002
650 DRUG LEVEL INCREASED 3 0.0002
651 RENAL IMPAIRMENT 15 0.0002
652 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
653 SCAR 3 0.0002
654 CARDIAC VALVE DISEASE 1 0.0002
655 DEHYDRATION 23 0.0002
656 ORTHOSTATIC HYPOTENSION 3 0.0002
657 ELECTROLYTE IMBALANCE 2 0.0002
658 CAESAREAN SECTION 2 0.0002
659 OSTEOPOROSIS 7 0.0002
660 DECREASED INTEREST 1 0.0002
661 LYMPHADENOPATHY 6 0.0002
662 HYPOTENSION 34 0.0002
663 DRUG ERUPTION 3 0.0002
664 DEEP VEIN THROMBOSIS 11 0.0002
665 CHOLECYSTITIS 2 0.0002
666 GASTROINTESTINAL DISORDER 15 0.0002
667 POLYNEUROPATHY 2 0.0002
668 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
669 DIABETIC KETOACIDOSIS 4 0.0002
670 OEDEMA 9 0.0002
671 RENAL FAILURE 22 0.0002
672 APHASIA 5 0.0002
673 INTERSTITIAL LUNG DISEASE 8 0.0002
674 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
675 CONJUNCTIVITIS 3 0.0002
676 CHOLANGITIS 1 0.0002
677 PHARYNGITIS 2 0.0002
678 DRUG-INDUCED LIVER INJURY 5 0.0002
679 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
680 SKIN ULCER 4 0.0002
681 ANGINA UNSTABLE 1 0.0002
682 NODULE 2 0.0002
683 DYSGRAPHIA 1 0.0002
684 IMMUNE SYSTEM DISORDER 2 0.0002
685 PULMONARY CONGESTION 2 0.0002
686 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
687 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
688 EAR INFECTION 4 0.0002
689 JOINT RANGE OF MOTION DECREASED 2 0.0001
690 FULL BLOOD COUNT DECREASED 3 0.0001
691 BRONCHIECTASIS 1 0.0001
692 FEEDING DISORDER 3 0.0001
693 IMPAIRED GASTRIC EMPTYING 2 0.0001
694 RASH ERYTHEMATOUS 7 0.0001
695 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
696 DIABETES MELLITUS 11 0.0001
697 RHABDOMYOLYSIS 6 0.0001
698 AUTOIMMUNE HEPATITIS 1 0.0001
699 COORDINATION ABNORMAL 2 0.0001
700 MASS 2 0.0001
701 OXYGEN SATURATION DECREASED 8 0.0001
702 PAIN IN JAW 4 0.0001
703 DIVERTICULUM 1 0.0001
704 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
705 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
706 CARDIAC FAILURE 11 0.0001
707 LABORATORY TEST ABNORMAL 4 0.0001
708 CARDIOMYOPATHY 2 0.0001
709 DRUG WITHDRAWAL SYNDROME NEONATAL 2 0.0001
710 DUODENAL ULCER PERFORATION 1 0.0001
711 COLON CANCER 2 0.0001
712 CARDIAC ARREST 11 0.0001
713 ECONOMIC PROBLEM 2 0.0001
714 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
715 CONGENITAL ANOMALY 1 0.0001
716 APNOEA 1 0.0001
717 DISORIENTATION 5 0.0001
718 COUGH 35 0.0001
719 ABDOMINAL PAIN 29 0.0001
720 SENSORY DISTURBANCE 2 0.0001
721 DIARRHOEA 80 0.0001
722 MUSCLE TIGHTNESS 2 0.0001
723 ATRIAL FIBRILLATION 12 0.0001
724 CEREBRAL INFARCTION 3 0.0001
725 HYPERTENSION 26 0.0001
726 DECUBITUS ULCER 1 0.0001
727 CHOLELITHIASIS 4 0.0001
728 LETHARGY 7 0.0001
729 GENERAL PHYSICAL HEALTH DETERIORATION 14 0.0001
730 ACUTE CORONARY SYNDROME 1 0.0001
731 DECREASED APPETITE 28 0.0001
732 ATRIAL SEPTAL DEFECT 1 0.0001
733 CELLULITIS 6 0.0001
734 TYPE 2 DIABETES MELLITUS 4 0.0001
735 ABDOMINAL PAIN LOWER 3 0.0001
736 FACE OEDEMA 2 0.0001
737 HEMIPARESIS 2 0.0001
738 ACUTE KIDNEY INJURY 18 0.0001
739 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
740 MUSCULOSKELETAL DISCOMFORT 2 0.0001
741 CARDIAC MURMUR 1 0.0001
742 OEDEMA PERIPHERAL 14 0.0001
743 OFF LABEL USE 100 0.0001
744 EOSINOPHILIA 2 0.0001
745 GASTRITIS 3 0.0001
746 BRADYCARDIA 6 0.0001
747 VOMITING 53 0.0001
748 THIRST 2 0.0001
749 C-REACTIVE PROTEIN INCREASED 4 0.0001
750 BONE DISORDER 2 0.0001
751 TREATMENT NONCOMPLIANCE 6 0.0001
752 SKIN LESION 3 0.0001
753 AGRANULOCYTOSIS 2 0.0001
754 EYE SWELLING 4 0.0001
755 DEFORMITY 1 0.0001
756 DIARRHOEA HAEMORRHAGIC 1 0.0001
757 BLOOD SODIUM DECREASED 2 0.0001
758 HYPOCALCAEMIA 2 0.0001
759 ARRHYTHMIA 5 0.0001
760 PROTEINURIA 2 0.0001
761 DISEASE RECURRENCE 5 0.0001
762 PULMONARY FIBROSIS 2 0.0001
763 INFECTION 15 0.0001
764 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
765 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
766 CHILLS 12 0.0001
767 COELIAC DISEASE 1 0.0001
768 DISEASE PROGRESSION 12 0.0001
769 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
770 DRUG INTERACTION 16 0.0001
771 UPPER LIMB FRACTURE 2 0.0001
772 CONFUSIONAL STATE 16 0.0001
773 DYSPNOEA 56 0.0001
774 INFLUENZA 11 0.0001
775 FLUID RETENTION 5 0.0001
776 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
777 RIB FRACTURE 2 0.0001
778 DERMATITIS 2 0.0001
779 HALLUCINATION, VISUAL 2 0.0001
780 PULMONARY EMBOLISM 9 0.0001
781 HYPOTHYROIDISM 3 0.0001
782 JOINT INJURY 2 0.0001
783 NIGHT SWEATS 3 0.0001
784 RHINORRHOEA 6 0.0001
785 DECREASED ACTIVITY 1 0.0001
786 RASH PRURITIC 5 0.0001
787 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
788 MELAENA 2 0.0001
789 FUNGAL INFECTION 3 0.0001
790 STEVENS-JOHNSON SYNDROME 2 0.0001
791 TRANSAMINASES INCREASED 2 0.0001
792 NEOPLASM MALIGNANT 6 0.0001
793 COLITIS ULCERATIVE 4 0.0001
794 HAEMATURIA 3 0.0001
795 GASTRIC DISORDER 3 0.0001
796 NEPHROLITHIASIS 4 0.0001
797 CARDIAC FAILURE CONGESTIVE 7 0.0001
798 SKIN DISCOLOURATION 4 0.0001
799 SHOCK 2 0.0001
800 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
801 MUSCLE TWITCHING 2 0.0001
802 NEOPLASM PROGRESSION 3 0.0001
803 RASH MACULAR 3 0.0001
804 BLOOD CHOLESTEROL INCREASED 4 0.0001
805 ASTHENIA 32 0.0001
806 CEREBRAL HAEMORRHAGE 3 0.0001
807 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
808 BLOOD GLUCOSE DECREASED 4 0.0001
809 PARAESTHESIA 13 0.0001
810 RASH 36 0.0001
811 LIVER INJURY 2 0.0001
812 ABASIA 2 0.0001
813 CYST 1 0.0001
814 HYPOAESTHESIA 12 0.0001
815 PNEUMONIA ASPIRATION 2 0.0001
816 DERMATITIS ALLERGIC 1 0.0001
817 MUSCULAR WEAKNESS 9 0.0001
818 FLUSHING 8 0.0001
819 CONSTIPATION 17 0.0001
820 DRUG RESISTANCE 2 0.0001
821 ANAPHYLACTIC SHOCK 2 0.0001
822 RASH GENERALISED 2 0.0001
823 RESPIRATORY TRACT INFECTION 2 0.0001
824 PRODUCT USE IN UNAPPROVED INDICATION 19 0.0001
825 ABDOMINAL DISTENSION 8 0.0001
826 SPEECH DISORDER 4 0.0001
827 JOINT STIFFNESS 2 0.0001
828 CONDITION AGGRAVATED 23 0.0001
829 INFUSION RELATED REACTION 5 0.0001
830 HYPERSENSITIVITY 14 0.0001
831 BLOOD PRESSURE DECREASED 5 0.0001
832 DEPRESSION 17 0.0001
833 FREQUENT BOWEL MOVEMENTS 2 0.0001
834 LIMB INJURY 2 0.0001
835 PALLOR 2 0.0001
836 RESPIRATORY ARREST 2 0.0001
837 FEELING COLD 2 0.0001
838 CARDIO-RESPIRATORY ARREST 3 0.0001
839 WEIGHT DECREASED 20 0.0001
840 URINARY TRACT INFECTION 12 0.0001
841 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
842 RECTAL HAEMORRHAGE 3 0.0001
843 HYPOACUSIS 3 0.0001
844 MOBILITY DECREASED 5 0.0001
845 NAUSEA 55 0.0001
846 ACCIDENTAL UNDERDOSE 1 0.0001
847 MENTAL DISORDER 3 0.0001
848 BACK PAIN 16 0.0001
849 APATHY 1 0.0001
850 INTENTIONAL PRODUCT MISUSE 6 0.0001
851 DYSPHONIA 4 0.0001
852 SINUSITIS 7 0.0001
853 AGITATION 5 0.0001
854 ACUTE MYOCARDIAL INFARCTION 2 0.0001
855 THROAT IRRITATION 3 0.0001
856 ADVERSE DRUG REACTION 6 0.0001
857 OROPHARYNGEAL PAIN 6 0.0001
858 GYNAECOMASTIA 2 0.0001
859 NERVOUS SYSTEM DISORDER 2 0.0001
860 BRAIN FOG 1 0.0001
861 GAIT DISTURBANCE 12 0.0001
862 MOVEMENT DISORDER 2 0.0001
863 THROMBOSIS 5 0.0001
864 BLOOD POTASSIUM INCREASED 1 0.0001
865 PAIN IN EXTREMITY 18 0.0001
866 HEART RATE INCREASED 6 0.0001
867 TREATMENT FAILURE 5 0.0001
868 VISUAL ACUITY REDUCED 2 0.0001
869 VIRAL INFECTION 2 0.0001
870 SKIN DISORDER 2 0.0001
871 URTICARIA 10 0.0001
872 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
873 HEPATIC ENZYME INCREASED 4 0.0001
874 ERYTHEMA 12 0.0001
875 INFLAMMATION 3 0.0001
876 INJURY 4 0.0001
877 COLD SWEAT 1 0.0001
878 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
879 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
880 RESTLESSNESS 2 0.0001
881 SUICIDAL IDEATION 5 0.0001
882 BLOOD GLUCOSE ABNORMAL 1 0.0001
883 DYSGEUSIA 4 0.0001
884 EPISTAXIS 4 0.0001
885 MALAISE 23 0.0001
886 EYE IRRITATION 3 0.0001
887 PLASMA CELL MYELOMA 2 0.0001
888 CHOKING 1 0.0001
889 DISABILITY 1 0.0001
890 BLOOD PRESSURE ABNORMAL 1 0.0001
891 SYNCOPE 5 0.0000
892 DRY MOUTH 4 0.0000
893 BODY TEMPERATURE INCREASED 1 0.0000
894 VISUAL IMPAIRMENT 6 0.0000
895 PRODUCT USE ISSUE 9 0.0000
896 BALANCE DISORDER 4 0.0000
897 VAGINAL HAEMORRHAGE 2 0.0000
898 BLOOD PRESSURE INCREASED 7 0.0000
899 COVID-19 8 0.0000
900 INJECTION SITE PRURITUS 3 0.0000
901 SOMNOLENCE 9 0.0000
902 CHROMATURIA 1 0.0000
903 PRURITUS 17 0.0000
904 RENAL DISORDER 2 0.0000
905 TREMOR 7 0.0000
906 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
907 OCULAR HYPERAEMIA 2 0.0000
908 DYSPHAGIA 4 0.0000
909 ABDOMINAL DISCOMFORT 7 0.0000
910 BLOOD PRESSURE FLUCTUATION 1 0.0000
911 JOINT SWELLING 5 0.0000
912 EMOTIONAL DISTRESS 5 0.0000
913 ARTHRALGIA 17 0.0000
914 DYSPEPSIA 4 0.0000
915 AGGRESSION 2 0.0000
916 HOT FLUSH 3 0.0000
917 UNEVALUABLE EVENT 3 0.0000
918 PAIN 24 0.0000
919 HOSPITALISATION 6 0.0000
920 LOSS OF CONSCIOUSNESS 5 0.0000
921 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
922 DIPLOPIA 1 0.0000
923 MUSCULOSKELETAL PAIN 2 0.0000
924 DRY SKIN 5 0.0000
925 FATIGUE 29 0.0000
926 BLOOD GLUCOSE INCREASED 7 0.0000
927 DISTURBANCE IN ATTENTION 2 0.0000
928 VISION BLURRED 5 0.0000
929 HAEMATOCHEZIA 2 0.0000
930 ANAPHYLACTIC REACTION 2 0.0000
931 DIVERTICULITIS 1 0.0000
932 WEIGHT INCREASED 8 0.0000
933 BLISTER 2 0.0000
934 EYE PAIN 2 0.0000
935 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
936 DYSSTASIA 1 0.0000
937 MUSCULOSKELETAL STIFFNESS 3 0.0000
938 BONE PAIN 2 0.0000
939 HEADACHE 21 0.0000
940 IRRITABILITY 2 0.0000
941 CORONARY ARTERY DISEASE 1 0.0000
942 MUSCLE SPASMS 6 0.0000
943 DRUG ADMINISTRATION ERROR 1 0.0000
944 PERIPHERAL SWELLING 5 0.0000
945 CHEST PAIN 6 0.0000
946 SWELLING 3 0.0000
947 BONE DENSITY DECREASED 1 0.0000
948 CYSTITIS 1 0.0000
949 DRUG INTOLERANCE 3 0.0000
950 SWELLING FACE 2 0.0000
951 MYALGIA 5 0.0000
952 ABDOMINAL PAIN UPPER 6 0.0000
953 DELIRIUM 1 0.0000
954 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
955 CRYING 1 0.0000
956 FALL 9 0.0000
957 BRONCHITIS 2 0.0000
958 DYSARTHRIA 1 0.0000
959 CHRONIC KIDNEY DISEASE 2 0.0000
960 PALPITATIONS 3 0.0000
961 DEATH 22 0.0000
962 DEVICE BREAKAGE 1 0.0000
963 ANXIETY 7 0.0000
964 INFLUENZA LIKE ILLNESS 2 0.0000
965 DRUG DOSE OMISSION 4 0.0000
966 DIZZINESS 12 0.0000
967 COMPLETED SUICIDE 2 0.0000
968 PRODUCT DOSE OMISSION ISSUE 7 0.0000
969 TOXICITY TO VARIOUS AGENTS 4 0.0000
970 SKIN EXFOLIATION 2 0.0000
971 COGNITIVE DISORDER 1 0.0000
972 CARDIAC DISORDER 2 0.0000
973 COMA 1 0.0000
974 CONTUSION 2 0.0000
975 DRY EYE 1 0.0000
976 CHEST DISCOMFORT 2 0.0000
977 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
978 DERMATITIS ATOPIC 1 0.0000
979 INSOMNIA 5 0.0000
980 DRUG EFFECT DECREASED 1 0.0000
981 DRUG INEFFECTIVE 24 0.0000
982 SEIZURE 2 0.0000
983 CATARACT 1 0.0000
984 FEELING ABNORMAL 4 0.0000
985 INJECTION SITE ERYTHEMA 2 0.0000
986 HYPERHIDROSIS 2 0.0000
987 DEVICE EXPULSION 1 0.0000
988 AMNESIA 1 0.0000
989 ALOPECIA 3 0.0000
990 MEMORY IMPAIRMENT 2 0.0000
991 OVERDOSE 3 0.0000
992 ARTHRITIS 1 0.0000
993 CEREBROVASCULAR ACCIDENT 2 0.0000
994 INJECTION SITE PAIN 3 0.0000
995 ASTHMA 1 0.0000
996 INCORRECT DOSE ADMINISTERED 2 0.0000